4//SEC Filing
Tupper Colleen 4
Accession 0001062993-23-003477
CIK 0001267565other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:17 PM ET
Size
9.8 KB
Accession
0001062993-23-003477
Insider Transaction Report
Form 4
Tupper Colleen
EVP & Chief Financial Officer
Transactions
- Award
Common Stock
2023-02-10+45,045→ 135,349 total - Award
Common Stock
2023-02-10+12,565→ 147,914 total - Tax Payment
Common Stock
2023-02-10$26.75/sh−6,967$186,367→ 140,947 total - Tax Payment
Common Stock
2023-02-10$26.75/sh−3,887$103,977→ 137,060 total
Footnotes (4)
- [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
- [F2]Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 12,565 performance share units granted in the issuer's three prior fiscal years.
- [F3]Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F4]Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001862082
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:17 PM ET
- Size
- 9.8 KB